Where to buy Sotorasib

Sotorasib (Sotorasib) is a promising KRAS G12C inhibitor that increases available treatment options for patients with KRAS G12C mutation-positive non-small cell lung cancer who have previously received platinum-based chemotherapy and/or immunotherapy. SotoraxibThe original drug has not yet been launched in China, so it is not included in the scope of medical insurance. Domestic patients cannot yet purchase this drug. To purchase this drug overseas, you need to purchase it through formal channels.

Sotoraxib was studied in an open-label, multicenter Phase I/II CodeBreaK 100 trial in the treatment of KRAS G12C mutation-positive non-small cell lung cancer in patients with advanced, previously treated KRAS G12C mutation-positive solid tumors. Data from the Phase I portion of the trial demonstrated the potential efficacy of once-daily sotoraxib 180-960 mg (the primary endpoint was safety), with 19 (32.2%) patients with non-small cell lung cancer achieving confirmed partial responses (PR) .

The Hong Kong original research versionsotorasibuSpecificationsThe price of 120mg*240 tablets is about 80,000 yuan, and the European original research version 120mg*240 tablets is priced at about 44,040 yuan (the price may fluctuate due to the exchange rate), and the price is relatively expensive. There are also cheaper generic drugs for sale in other countries. The specifications of the Laos Element Pharmaceutical Factory are 120mg*56 tablets and the price is around 4800 RMB (the price may fluctuate due to the exchange rate). The price is relatively cheap. The ingredients of foreign generic drugs are basically the same as those of the original drugs. For specific prices and drug details, please consult the medical consultant of Yaode.